Precigen (PGEN) Invested Capital (2012 - 2026)

Precigen (PGEN) has reported Invested Capital for 12 consecutive years, with $13.8 million the latest figure, recorded in Q1 2023.

• In Q1 2023, Invested Capital rose 8326.22% year-over-year to $13.8 million; the TTM figure through Dec 2023 stood at $13.8 million (down 89.01% YoY), while the FY2022 annual figure was $43.2 million, up 58304.05% from the prior year.
• Invested Capital slipped to $13.8 million in Q1 2023 per PGEN's latest filing, from $43.2 million in the prior quarter.
• Across five years, Invested Capital topped out at $82.1 million in Q3 2022 and bottomed at $19000.0 in Q4 2020.
• Historically, Invested Capital has averaged $8.9 million across 5 years, with a median of $169500.0 in 2020.
• Annual changes were most pronounced in 2020 — Invested Capital plunged 93.31% — and 2022, when it surged 58304.05%.
• Precigen's Invested Capital stood at $51000.0 in 2019, then tumbled by 62.75% to $19000.0 in 2020, then jumped by 289.47% to $74000.0 in 2021, then soared by 58304.05% to $43.2 million in 2022, then tumbled by 68.03% to $13.8 million in 2023.
• Business Quant data shows PGEN's Invested Capital at $13.8 million in Q1 2023, $43.2 million in Q4 2022, and $82.1 million in Q3 2022.